Heres why this move deserves attention Big Bet on a Blockbuster Segment Entry into the fast-growing GLP-1 (semaglutide) space Taps into a market set to explode with rising diabetes & obesity cases Timed perfectly post patent expiry early-mover advantage Product That Matches Global Standards Once-weekly injectable better patient adherence Available in 2 mg & 4 mg pre-filled pens Backed by Phase III data comparable efficacy + strong safety Premium Generic Strategy (Not a Price WarYet) Priced at ~4,200/month Positioned as a trusted, high-quality branded generic Targets urban, quality-conscious patients over deep discounting Full-Stack Manufacturing Power API + formulation + delivery device all in-house Strong edge in complex peptides & scale-up capability Sets the stage for global expansion Beyond Drug: Building a Patient Ecosystem SemaKare support program Focus on adherence, education & outcomes Shift from product-selling solution-building Competitive Storm Incoming Multiple Indian pharma giants entering semaglutide Likely outcomes: Price erosion Wider access Massive market expansion The Real Play
doi: 10.1016/0091-3057(76)90331-2
persistent or recurrent mucocoeles are treated by surgical excision (removing the cyst and the underlying minor salivary gland) or marsupialisation (deroofing)
People struggling with memory or concentration issues, or those looking to enhance their mental clarity , can also see improvements from B12 injections
155,156,157 Uricase, an enzyme responsible for converting UA into allantoin and urea, is found in various bacterial species including Bacillus pasteurii, Proteus mirabilis, and E
These observations are largely from rodent models and have not been demonstrated in humans
